Fentanyl Citrate Solubility UK 101: It's The Complete Guide For Beginners

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This short article is intended for instructional and expert info functions just. Fentanyl citrate is a Class A controlled substance in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formulation should just be performed by licensed professionals in controlled environments.

In the world of pharmacology and scientific medication, fentanyl citrate stays among the most potent artificial opioids offered. Due to its high effectiveness and rapid onset of action, it is a cornerstone of pain management and anaesthesia in the UK's National Health Service (NHS) and private health care sectors. However, the pharmacological effectiveness of any drug is fundamentally linked to its physicochemical homes-- specifically its solubility.

Comprehending the solubility of fentanyl citrate is important for pharmacists, scientists, and clinicians to make sure stable formulas, accurate dosing, and reliable drug shipment throughout different administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it possesses restricted solubility in liquid environments. By responding the base with citric acid, moving into the salt type (fentanyl citrate), the solubility in water is significantly improved. This makes it ideal for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is manufactured according to the standards set by the British Pharmacopoeia (BP). It usually looks like a white, crystalline powder or as granules that are odorless.

Key Physicochemical Properties

Property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Around 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate differs drastically depending


on the solvent used and the ambient temperature level. In

a pharmaceutical setting, water is the main solvent of interest for injectables, however organic solvents are typically used during the production of transdermal patches or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most typically encountered as a 50 mcg/mL solution for injection. At room temperature level(around 20 ° C to 25 ° C), fentanyl

citrate is considered"sparingly soluble"in water. Scientific literature usually recommends a solubility limitation of approximately 25 mg/mL in water at 25 ° C, which is more than enough for standard clinical concentrations. Organic Solvent Solubility Fentanyl citrate displays diverse solubility in organic solvents, which is vital for developing non-aqueous drug delivery systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Moderately Soluble ~ 25 mg/mL Methanol Easily Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol A little Soluble

<10 mg/mL Aspects Influencing Solubility and Stability The solubility of fentanyl citrate is not a fixed worth; it

is influenced by several ecological and chemical aspects that should be controlled during intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate stays highly soluble in acidic to neutral options. The majority of UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of an option increases substantially above 7.5, there is a risk that the fentanyl


will shift back into its base kind. Because the base

form is significantly less soluble in water, this can result in"crashing out"or precipitation, which is incredibly hazardous in an IV setting. 2. Temperature Effects Like a lot of crystalline solids, the solubility of fentanyl citrate increases with temperature. While this is useful throughout the industrial dissolution process, it postures a threat during storage . If a saturated service is prepared at a high temperature level and after that cooled (such as during transport in cold UK winters), the solute may take shape. 3. Existence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the option can reduce the solubility of fentanyl citrate due to the typical ion result. This is a vital factor to consider when blending fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The choice of buffer(e.g., salt citrate or phosphate buffers)is

critical in maintaining a stable environment where the drug stays in its ionized, soluble kind. Formulating for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medical products need to abide by the British Pharmacopoeia(BP). The BP supplies specific essays for Fentanyl Citrate, guaranteeing purity, strength, and solubility requirements are fulfilled. Secret Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral options be clear and devoid of noticeable particles. This is achieved by ensuring the concentration remains well below the saturation point. Sterility: Given the liquid nature of the solution, formulations need to be

### decontaminated, normally

by means of autoclaving or filtering, which can affect the stability if the solubility limits are tight. Excipients: Common additives in UK fentanyl formulas consist of Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH adjustment). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the healthcare specialist? Preventing Precipitation: Knowing that fentanyl is incompatible with extremely alkaline

**options(like thiopentone or some bicarbonate services

*   **)prevents the formation of precipitates that could trigger embolic occasions. Optimizing Drug Delivery: In the advancement of sublingual or buccal tablets (e.g., Abstral or Effentora utilized in the UK), the drug should dissolve*   **rapidly in the small volume of saliva offered. Transdermal Flux: While patches depend on the lipophilicity of the fentanyl base, the manufacture of these spots frequently involves dissolving the citrate salt in an unstable solvent*   **before it is impregnated into the adhesive matrix. Storage and Handling Recommendations To preserve the solubility and efficacy of fentanyl citrate products, the following guidelines are generally

            * * *

            followed in British scientific settings: Temperature
            ----------------------------------------------------

            Control: Store at regulated room temperature level (15 ° C to 25 ° C). Prevent freezing, as this can lead to irreparable precipitation in**specific formulas. Light** Protection: Fentanyl citrate is somewhat light-sensitive. Aqueous options ought to be kept in amber glass or opaque product packaging. Dealing with Potency: Because of its high solubility and effectiveness, unintentional skin contact*   **with focused services** can lead to systemic absorption. Expert PPE is necessary. Frequently Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is created particularly to increase aqueous solubility, making it appropriate for injections. The base kind is extremely lipophilic and is typically used in the internal layers of transdermal patches. Does the UK BP(British Pharmacopoeia)differ

                from the USP relating to solubility? The basic

                solubility profiles equal as they explain the very same chemical entity. Nevertheless, the specific screening approaches and the prioritized solvents for pureness screening may vary

                *   **a little between the BP** and the United States Pharmacopeia (USP). Can I blend fentanyl citrate with saline? Yes. Fentanyl citrate works with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents utilized in UK hospitals. What takes [learn more](https://pad.geolab.space/s/eq3C-WtFh) if a fentanyl service becomes cloudy? If a service of fentanyl citrate appears cloudy or includes** crystals, it must be disposed of. This suggests that the drug has actually precipitated out of the service, either due to pH modifications, temperature shifts, or contamination.

                * * *

                Why is citric acid used specifically?
                -------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade organic acid. It forms a steady salt with fentanyl that uses a balance of high water solubility and compatible pH for human tissue. Fentanyl citrate is a vital medicinal tool in the UK, but its safety and efficacy are predicated on

                ### its chemical stability. Solubility is maybe the most important factor in this regard

                . By keeping an ideal pH, selecting the correct solvents, and sticking to British Pharmacopoeia standards, the pharmaceutical market makes sure that this powerful analgesic stays a trusted option for patient care.

                ### For clinicians, the takeaway is simple: always validate compatibility before mixing and ensure storage conditions are strictly met to avoid the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 23 May 2026 17:16 UTC

Views: 2